Ectoine

CAS No. 96702-03-3

Ectoine( Ectoine )

Catalog No. M17696 CAS No. 96702-03-3

Ectoine is an osmoprotectant in a variety of microorganisms including halophilic and heterotrophic bacteria and non-halophilic bacteria such as the Streptomyces species, as well as E.coli.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ectoine
  • Note
    Research use only, not for human use.
  • Brief Description
    Ectoine is an osmoprotectant in a variety of microorganisms including halophilic and heterotrophic bacteria and non-halophilic bacteria such as the Streptomyces species, as well as E.coli.
  • Description
    Ectoine is an inhibitor of protein misfolding. It acts by significantly down-regulating Syp, Mapk3 and Tnfα and up-regulating Vegf in rat's hippocampus, prohibiting insulin amyloid formation in vitro.(In Vitro):Ectoine (0-5% (w/v); 0-24 h; human erythrocytes) protects the cells from damage caused by SDS treatment.
  • In Vitro
    Ectoine (0-5% (w/v); 0-24 h; human erythrocytes) protects the cells from damage caused by SDS treatment.
  • In Vivo
    ——
  • Synonyms
    Ectoine
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96702-03-3
  • Formula Weight
    142.16
  • Molecular Formula
    C6H10N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 250 mg/mL (1758.58 mM)
  • SMILES
    C1(=N[C@@H](CCN1)C(=O)O)C
  • Chemical Name
    (6S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-6-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Meyer S., et al. Ectoine can enhance structural changes in DN/A in vitro. Sci Rep. 2017 Aug 3;7(1):7170.
molnova catalog
related products
  • Sapanisertib

    Sapanisertib (INK-128, MLN0128) is a potent, ATP-competitive, orally active dual mTORC1/2 inhibitor with Ki of 1.4 nM in cell-free assays.

  • CNX-2006

    CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.

  • DMH-25

    DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.